Afamin (AFM) (C-Term) Peptide
-
- Target See all Afamin (AFM) products
- Afamin (AFM)
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- HADMCQSQNE ELQRKTDRFL VNLVKLKHEL TDEELQSLFT NFANVVDKCC
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-AFM Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Afamin (AFM)
- Background
-
AFM is a member of the albumin gene family, which is comprised of four genes that localize to chromosome 4 in a tandem arrangement. These four genes encode structurally-related serum transport proteins that are known to be evolutionarily related. AFM is regulated developmentally, expressed in the liver and secreted into the bloodstream.
Alias Symbols: ALB2, ALBA, ALF, MGC125338, MGC125339
Protein Size: 599 - Molecular Weight
- 67 kDa
- Gene ID
- 173
- NCBI Accession
- NM_001133, NP_001124
- UniProt
- P43652
-